Organisation: Pfizer

Pfizer unit awarded $108 million for AstraZeneca infringement by Delaware jury

But big money pharma patent damages have a habit of being overturned

21 May 2024

Moderna’s surprise EPO win is a boost for its flagging European patent assertions

But the covid-19 jab maker must overcome several more hurdles to get its hands on a slice of Pfizer/BioNTech’s vaccine revenues

20 May 2024

GSK becomes latest mRNA patentee to enter covid IP wars, increasing pressure on Pfizer/BioNTech

Meanwhile BioNTech and Moderna face off in the UK, and another mRNA spat settles

29 April 2024

J&J trade secret spat shines light on company’s strategy

The case is latest of many recent life sciences confidential information disputes

02 April 2024

BioNTech facing fresh mRNA spat in vaccine patent royalties dispute

The covid-19 IP war’s most prolific defendant finds itself on the brink of litigation in another fight

27 March 2024

IAM’s Market Makers of 2023

Via Licensing Alliance’s Heath Hoglund takes the top spot in our annual ranking of the patent market’s most innovative and influential deal makers and decision takers

14 March 2024

mRNA firms and other biopharma patentees dominate ‘Innovation Momentum’ rankings

Newly released report throws light on which life sciences companies have the most dynamic IP portfolios

22 February 2024

mRNA trade secrets to become even more important, says WHO vaccine hub boss

IAM talked with Petro Terblanche, CEO of Afrigen Biologics, about the WHO vaccine hub and its IP strategy

21 February 2024

Five stories that made 2023 a momentous year for life sciences IP

The dawn of a new era for CRISPR patent strategy, multiplying mRNA patent wars, and 10x Genomics and NanoString’s cross-border spat were among the developments that defined the last 12 months

02 January 2024

Tracing the digital footprints of a trade secret thief

Digital forensics investigators share their advice for being one step ahead of critical information leaks

15 December 2023